Beta-human chorionic gonadotropin in semen: A marker for early detection of prostate cancer?

Molecular Urology

Volumn 4, Issue 4, 2000, Pages 421-427

  Daja, M M ^a   Aghmesheh, M ^a   Ow, K T ^a   Rohde, P R ^a   Barrow, K D ^a   Russell, P J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SECRETION; PROTEIN EXPRESSION; SEMEN ANALYSIS; SPERM;

ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MALE; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMEN; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033635517     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Prostate-specific antigen and early detection of prostate cancer
2. Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
3. The value of a reverse-transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer
4. Re: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: A clinicopathological molecular analysis of 121 patients
5. Individual prostate-specific antigen (PSA) forms as prostate tumor markers
6. Human chorionic gonadotropin β subunit gene expression in cultured human fetal and cancer cells of different types and origins
7. Metastatic phenotype correlates with high expression of membrane-associated complete β-human chorionic gonadotropin in vivo
8. The β-core fragment of human chorionic gonadotropin: Biochemical background and clinical application
9. β-hCG as a prognostic marker in adenocarcinoma of the prostate
10. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers
11. Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients
12. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer
13. Expression of human chorionic gonadotropin β subunit genes in superficial and invasive bladder carcinomas
14. Production of trophoblastic hormones by transitional cell carcinoma of the bladder: Association to tumor stage and grade
15. Clinical use of hCG and hCG-beta determinations
16. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotropin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer
17. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotropin as prognostic markers for epithelial ovarian cancer
18. Human chorionic gonadotropin-beta in the differentiation of malignancy-related and non-malignant ascites
19. Detection of metastatic breast cancer by β-hCG polymerase chain reaction
20. Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate
21. Abnormal prostatic cells in ejaculates from men with prostatic cancer: A preliminary report
22. The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinoma
23. A highly sensitive method for one-step amplification of RNA by polymerase chain reaction
24. Prognostic value of chorionic gonadotropin β gene transcripts in human breast carcinoma
25. Expression of alpha and beta genes of human chorionic gonadotropin in lung
26. Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma